Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC -- critique. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (6994)	1/6/2001 10:10:32 AM
From: Tom Clarke	Respond to of 17683

Business Week apologizes for lifting material from the Washington Post. In our issue of Oct. 30, 2000, we ran an article called ''Surf at your own risk'' (page 143). It described how a Boston-based company, Pharmatrak Inc., surreptitiously tracked computer users who visited the Web sites of 11 pharmaceutical companies. Unfortunately, the article used information and wording without attribution from a similar story that ran earlier in The Washington Post. We deeply regret this incident. We apologize to our readers and to The Washington Post for this breach of journalistic standards. businessweek.com

To: scaram(o)uche who wrote (6994)	1/8/2001 12:49:25 AM
From: Toby Zidle	Read Replies (1) \| Respond to of 17683

Rick, perhaps you will address the difference between ^BTK and ^DRG. "Teach him what ^BTK is, that it's an average of mostly OPERATIONAL companies, not research boutiques. These companies produce DRUGS, and are therefore relatively recession-strong." It's my impression that the big OPERATIONAL companies are in the ^DRG, e.g., MRK, LLY, JNJ, PFE, etc. I thought the ^BTK stocks are the RESEARCH-heavy group, e.g., SEPR et al. AMGN is the only company that the two indices have in common. Toby